The missing Zinc: P53 misfolding and cancer

Metallomics

Volumn 2, Issue 7, 2010, Pages 442-449

  Loh, Stewart N ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOCHAPERONE; PROTEIN P53; ZINC ION;

CARCINOGENESIS; DNA BINDING; GENE MUTATION; HUMAN; METAL BINDING; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW; TRANSCRIPTION INITIATION;

HUMANS; MODELS, MOLECULAR; NEOPLASMS; PROTEIN FOLDING; TUMOR SUPPRESSOR PROTEIN P53; ZINC;

EID: 77954681706     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c003915b     Document Type: Review

References (96)

1. C. Andreini L. Banci I. Bertini A. Rosato Counting the zinc-proteins encoded in the human genome J. Proteome Res. 2006 5 196 201
2. A. I. Anzellotti N. P. Farrell Zinc metalloproteins as medicinal targets Chem. Soc. Rev. 2008 37 1629 1651
3. W. Maret Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc Exp. Gerontol. 2008 43 363 369
4. K. A. Jackson R. A. Valentine L. J. Coneyworth J. C. Mathers D. Ford Mechanisms of mammalian zinc-regulated gene expression Biochem. Soc. Trans. 2008 36 1262 1266
5. D. R. Green G. Kroemer Cytoplasmic functions of the tumour suppressor p53 Nature 2009 458 1127 1130
6. J. M. Nigro S. J. Baker A. C. Presinger J. M. Jessup R. Hostetter K. Cleary S. H. Bigner N. Davidson S. Baylin P. Devilee B. Vogelstein Mutations in the p53 gene occur in diverse human tumour types Nature 1989 342 705 708
7. S. Jones X. Zhang D. W. Parsons J. C. Lin R. J. Leary P. Angenendt P. Mankoo H. Carter H. Kamiyama A. Jimeno S. M. Hong B. Fu M. T. Lin E. S. Calhoun M. Kamiyama K. Walter T. Nikolskaya Y. Nikolsky J. Hartigan D. R. Smith M. Hidalgo S. D. Leach A. P. Klein E. M. Jaffee M. Goggins A. Maitra C. Iacobuzio-Donahue J. R. Eshleman S. E. Kern R. H. Hruban R. Karchin N. Papadopoulos G. Parmigiani B. Vogelstein V. E. Velculescu K. W. Kinzler Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 2008 321 1801 1806
8. D. W. Parsons S. Jones X. Zhang J. C. Lin R. J. Leary P. Angenendt P. Mankoo H. Carter I. M. Siu G. L. Gallia A. Olivi R. McLendon B. A. Rasheed S. Keir T. Nikolskaya Y. Nikolsky D. A. Busam H. Tekleab L. A. Diaz, Jr. J. Hartigan D. R. Smith R. L. Strausberg S. K. Marie S. M. Shinjo H. Yan G. J. Riggins D. D. Bigner R. Karchin N. Papadopoulos G. Parmigiani B. Vogelstein V. E. Velculescu K. W. Kinzler An integrated genomic analysis of human glioblastoma multiforme Science 2008 321 1807 1812
9. W. Xue L. Zender C. Miething R. A. Dickins E. Hernando V. Krizhanovsky C. Cordon-Cardo S. W. Lowe Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas Nature 2007 445 656 660
10. A. Ventura D. G. Kirsch M. E. McLaughlin D. A. Tuveson J. Grimm L. Lintault J. Newman E. E. Reczek R. Weissleder T. Jacks Restoration of p53 function leads to tumour regression in vivo Nature 2007 445 661 665
11. T. Kawaguchi S. Kato K. Otsuka G. Watanabe T. Kumabe T. Tominaga T. Yoshimoto C. Ishioka The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library Oncogene 2005 24 6976 6981
12. J. A. Pietenpol T. Tokino S. Thiagalingam W. S. El-Deiry K. W. Kinzler B. Vogelstein Sequence-specific transcriptional activation is essential for growth suppression by p53 Proc. Natl. Acad. Sci. U. S. A. 1994 91 1998 2002
13. E. Natan D. Hirschberg N. Morgner C. V. Robinson A. R. Fersht Ultraslow oligomerization equilibria of p53 and its implications Proc. Natl. Acad. Sci. U. S. A. 2009 106 14327 14332
14. K. Sakaguchi H. Sakamoto M. S. Lewis C. W. Anderson J. W. Erickson E. Appella D. Xie Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53 Biochemistry 1997 36 10117 10124
15. Y. Cho S. Gorina P. D. Jeffrey N. P. Pavletich Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations Science 1994 265 346 355
16. W. C. Ho M. X. Fitzgerald R. Marmorstein Structure of the p53 core domain dimer bound to DNA J. Biol. Chem. 2006 281 20494 20502
17. M. Kitayner H. Rozenberg N. Kessler D. Rabinovich L. Shaulov T. E. Haran Z. Shakked Structural basis of DNA recognition by p53 tetramers Mol. Cell 2006 22 741 753
18. K. A. Malecka W. C. Ho R. Marmorstein Crystal structure of a p53 core tetramer bound to DNA Oncogene 2009 28 325 333
19. M. Kitayner H. Rozenberg R. Rohs O. Suad D. Rabinovich B. Honig Z. Shakked Diversity in DNA recognition by p53 revealed by crystal structures with Hoogsteen base pairs Nat. Struct. Mol. Biol. 2010 17 423 429
20. D. J. Lubin J. S. Butler S. N. Loh Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function J. Mol. Biol. 2010 395 705 716
21. S. Bell C. Klein L. Müller S. Hansen J. Buchner p53 contains large unstructured regions in its native state J. Mol. Biol. 2002 322 917 927
22. A. N. Bullock J. Henckel B. S. DeDecker C. M. Johnson P. V. Nikolova M. R. Proctor D. P. Lane A. R. Fersht Thermodynamic stability of wild-type and mutant p53 core domain Proc. Natl. Acad. Sci. U. S. A. 1997 94 14338 14342
23. A. N. Bullock J. Henckel A. R. Fersht Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy Oncogene 2000 19 1245 1256
24. N. P. Pavletich K. A. Chambers C. O. Pabo The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots Genes Dev. 1993 7 2556 2564
25. C. Méplan M.-J. Richard P. Hainaut Redox signalling and transition metals in the control of the p53 pathway Biochem. Pharmacol. 2000 59 25 33
26. J. S. Butler S. N. Loh Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain Biochemistry 2003 42 2396 2403
27. J. Alsner V. Jensen M. Kyndi B. V. Offersen P. Vu A. L. Borresen-Dale J. Overgaard A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients Acta Oncologica 2008 47 600 607 (Pubitemid 351878460)
28. M. Olivier A. Langerod P. Carrieri J. Bergh S. Klaar J. Eyfjord C. Theillet C. Rodriguez R. Lidereau I. Bieche J. Varley Y. Bignon N. Uhrhammer R. Winqvist A. Jukkola-Vuorinen D. Niederacher S. Kato C. Ishioka P. Hainaut A. L. Borresen-Dale The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer Clin. Cancer Res. 2006 12 1157 1167
29. H. J. van Slooten M. J. van De Vijver A. L. Borresen J. E. Eyfjord R. Valgardsdottir S. Scherneck J. M. Nesland P. Devilee C. J. Cornelisse J. H. van Dierendonck Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma J. Pathol. 1999 189 504 513
30. M. Gentile M. Bergman Jungestrom K. E. Olsen P. Soderkvist S. Wingren p53 and survival in early onset breast cancer: analysis of gene mutations, loss of heterozygosity and protein accumulation Eur. J. Cancer 1999 35 1202 1207
31. A. Russo V. Bazan B. Iacopetta D. Kerr T. Soussi N. Gebbia The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment J. Clin. Oncol. 2005 23 7518 7528
32. A. Russo M. Migliavacca I. Zanna M. R. Valerio M. A. Latteri N. Grassi G. Pantuso S. Salerno G. Dardanoni I. Albanese M. La Farina R. M. Tomasino N. Gebbia V. Bazan p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up Cancer Epidemiol. Biomarkers Prev. 2002 11 1322 1331
33. V. Skaug D. Ryberg E. H. Kure M. O. Arab L. Stangeland A. O. Myking A. Haugen p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients Clin. Cancer Res. 2000 6 1031 1037
34. C. Kihara T. Seki Y. Furukawa H. Yamana Y. Kimura P. van Schaardenburgh K. Hirata Y. Nakamura Mutations in zinc-binding domains of p53 as a prognostic marker of esophageal-cancer patients Jpn J. Cancer Res. 2000 91 190 198
35. M. Lokshin Y. Li C. Gaiddon C. Prives p53 and p73 display common and distinct requirements for sequence specific binding to DNA Nucleic Acids Res. 2007 35 340 352
36. 2+-dependent misfolding of the p53 DNA binding domain Biochemistry 2007 46 2630 2639
37. D. P. Liu H. Song Y. Xu A common gain of function of p53 cancer mutants in inducing genetic instability Oncogene 2010 29 949 956
38. J. S. Butler S. N. Loh Kinetic partitioning during folding of the p53 DNA binding domain J. Mol. Biol. 2005 350 906 918
39. J. S. Butler S. N. Loh Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature Protein Sci. 2006 15 2457 2465
40. Y. Xue S. Wang X. Feng Effect of metal ion on the structural stability of tumour suppressor protein p53 DNA-binding domain J. Biochem. 2009 146 193 200
41. Y. Xue S. Wang X. Feng Influence of magnesium ion on the binding of p53 DNA-binding domain to DNA-response elements J. Biochem. 2009 146 77 85
42. 2+ on DNA recognition and stability of the p53 DNA binding domain Biochemistry 2006 45 7483 7492
43. E. Kwon D. Y. Kim S. W. Suh K. K. Kim Crystal structure of the mouse p53 core domain in zinc-free state Proteins 2008 70 280 283
44. W. C. Ho C. Luo K. Zhao X. Chai M. X. Fitzgerald R. Marmorstein High-resolution structure of the p53 core domain: implications for binding small-molecule stabilizing compounds Acta Crystallogr., Sect. D: Biol. Crystallogr. 2006 62 1484 1493
45. K. Zhao X. Chai K. Johnston A. Clements R. Marmorstein Crystal structure of the mouse p53 core DNA-binding domain at 2.7 Å resolution J. Biol. Chem. 2001 276 12120 12127
46. A. Friedler L. O. Hansson D. B. Veprintsev S. M. Freund T. M. Rippin P. V. Nikolova M. R. Proctor S. Rüdiger A. R. Fersht A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants Proc. Natl. Acad. Sci. U. S. A. 2002 99 937 942
47. R. Rohs S. M. West A. Sosinsky P. Liu R. S. Mann B. Honig The role of DNA shape in protein-DNA recognition Nature 2009 461 1248 1253
48. D. N. Ivankov S. O. Garbuzynskiy E. Alm K. W. Plaxco D. Baker A. V. Finkelstein Contact order revisited: influence of protein size on the folding rate Protein Sci. 2003 12 2057 2062
49. C. Kayatekin J. A. Zitzewitz C. R. Matthews Zinc binding modulates the entire folding free energy surface of human Cu,Zn superoxide dismutase J. Mol. Biol. 2008 384 540 555
50. A. D. Pandit B. A. Krantz R. S. Dothager T. R. Sosnick Characterizing protein folding transition States using Psi-analysis Methods Mol. Biol. 2007 350 83 104
51. N. A. Bushmarina C. E. Blanchet G. Vernier V. Forge Cofactor effects on the protein folding reaction: acceleration of α-lactalbumin refolding by metal ions Protein Sci. 2006 15 659 671
52. J. A. Rumfeldt J. R. Lepock E. M. Meiering Unfolding and folding kinetics of amyotrophic lateral sclerosis-associated mutant Cu,Zn superoxide dismutases J. Mol. Biol. 2009 385 278 298
53. K. Teilum M. H. Smith E. Schulz L. C. Christensen G. Solomentsev M. Oliveberg M. Akke Transient structural distortion of metal-free Cu/Zn superoxide dismutase triggers aberrant oligomerization Proc. Natl. Acad. Sci. U. S. A. 2009 106 18273 18278
54. V. K. Mulligan A. Kerman S. Ho A. Chakrabartty Denaturational stress induces formation of zinc-deficient monomers of Cu,Zn superoxide dismutase: implications for pathogenesis in amyotrophic lateral sclerosis J. Mol. Biol. 2008 383 424 436
55. K. H. Khoo A. C. Joerger S. M. Freund A. R. Fersht Stabilising the DNA-binding domain of p53 by rational design of its hydrophobic core Protein Eng., Des. Sel. 2009 22 421 430
56. A. Friedler D. B. Veprintsev L. O. Hansson A. R. Fersht Kinetic instability of p53 core domain mutants J. Biol. Chem. 2003 278 24108 24112
57. D. Ishimaru L. R. Andrade L. S. P. Teixeira P. A. Quesado L. M. Maiolino P. M. Lopez Y. Cordeiro L. T. Costa W. M. Heckl G. Weissmüller D. Foguel J. L. Silva Fibrillar aggregates of the tumor suppressor p53 core domain Biochemistry 2003 42 9022 9027
58. D. Ishimaru A. P. Ano Bom L. M. Lima P. A. Quesado M. F. Oyama C. V. de Moura Gallo Y. Cordeiro J. L. Silva Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation Biochemistry 2009 48 6126 6135
59. M. O. Pedersen R. Jensen D. S. Pedersen A. D. Skjolding C. Hempel L. Maretty M. Penkowa Metallothionein-I+II in neuroprotection BioFactors 2009 35 315 325
60. T. Eckschlager V. Adam J. Hrabeta K. Figova R. Kizek Metallothioneins and cancer Curr. Protein Pept. Sci. 2009 10 360 375
61. P. Hainaut J. Milner Redox modulation of p53 conformation and sequence-specific DNA binding in vitro Cancer Res. 1993 53 4469 4473
62. T. R. Hupp D. W. Meek C. A. Midgley D. P. Lane Activation of the cryptic DNA binding function of mutant forms of p53 Nucleic Acids Res. 1993 21 3167 3174
63. R. Rainwater D. Parks M. E. Anderson P. Tegtmeyer Role of cysteine residues in regulation of p53 function Mol. Cell Biol. 1995 15 3892 3903
64. C. S. Stoner G. D. Pearson A. Koc J. R. Merwin N. I. Lopez G. F. Merrill Effect of thioredoxin deletion and p53 cysteine replacement on human p53 activity in wild-type and thioredoxin reductase null yeast Biochemistry 2009 48 9156 9169
65. A. Wolff A. Technau C. Ihling K. Technau-Ihling R. Erber F. X. Bosch G. Brandner Evidence that wild-type p53 in neuroblastoma cells is in a conformation refractory to integration into the transcriptional complex Oncogene 2001 20 1307 1317
66. M. Ueno H. Masutani R. J. Arai A. Yamauchi K. Hirota T. Sakai T. Inamoto Y. Yamaoka J. Yodoi T. Nikaido Thioredoxin-dependent redox regulation of p53-mediated p21 activation J. Biol. Chem. 1999 274 35809 35815
67. L. Jayaraman K. G. Murthy C. Zhu T. Curran S. Xanthoudakis C. Prives Identification of redox/repair protein Ref-1 as a potent activator of p53 Genes Dev. 1997 11 558 570
68. N. Leone D. Courbon P. Ducimetiere M. Zureik Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality Epidemiology 2006 17 308 314
69. T. Wu C. T. Sempos J. L. Freudenheim P. Muti E. Smit Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults Ann. Epidemiol. 2004 14 195 201
70. R. B. Franklin L. C. Costello Zinc as an antitumor agent in prostate cancer and in other cancers Arch. Biochem. Biophys. 2007 463 211 217
71. M. Murakami T. Hirano Intracellular zinc homeostasis and zinc signaling Cancer Sci. 2008 99 1515 1522
72. S. Gallus R. Foschi E. Negri R. Talamini S. Franceschi M. Montella V. Ramazzotti A. Tavani L. Dal Maso C. La Vecchia Dietary zinc and prostate cancer risk: a case-control study from Italy Eur. Urol. 2007 52 1052 1056
73. Y. Song S. W. Leonard M. G. Traber E. Ho Zinc deficiency affects DNA damage, oxidative stress, antioxidant defenses, and DNA repair in rats J. Nutr. 2009 139 1626 1631
74. M. S. Clegg L. A. Hanna B. J. Niles T. Y. Momma C. L. Keen Zinc deficiency-induced cell death IUBMB Life 2005 57 661 669
75. M. Yan Y. Song C. P. Wong K. Hardin E. Ho Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells J. Nutr. 2008 138 667 673
76. A. A. Alshatwi C. T. Han N. W. Schoene K. Y. Lei Nuclear accumulations of p53 and Mdm2 are accompanied by reductions in c-Abl and p300 in zinc-depleted human hepatoblastoma cells Exp. Biol. Med. (Maywood) 2006 231 611 618
77. E. Ho C. Courtemanche B. N. Ames Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts J. Nutr. 2003 133 2543 2548
78. E. Ho B. N. Ames Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line Proc. Natl. Acad. Sci. U. S. A. 2002 99 16770 16775
79. J. C. Fanzo S. K. Reaves L. Cui L. Zhu K. Y. Lei p53 protein and p21 mRNA levels and caspase-3 activity are altered by zinc status in aortic endothelial cells Am. J. Physiol. Cell Physiol. 2002 283 C631 638
80. J. C. Fanzo S. K. Reaves L. Cui L. Zhu J. Y. Wu Y. R. Wang K. Y. Lei Zinc status affects p53, gadd45, and c-fos expression and caspase-3 activity in human bronchial epithelial cells Am. J. Physiol. Cell Physiol. 2001 281 C751 757
81. C. Méplan M.-J. Richard P. Hainaut Metallogregulation of the tumor supressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells Oncogene 2000 19 5227 5236
82. A. Krezel W. Maret Dual nanomolar and picomolar Zn(ii) binding properties of metallothionein J. Am. Chem. Soc. 2007 129 10911 10921
83. R. Bozym T. K. Hurst N. Westerberg A. Stoddard C. A. Fierke C. J. Frederickson R. B. Thompson Determination of zinc using carbonic anhydrase-based fluorescence biosensors Methods Enzymol. 2008 450 287 309
84. R. A. Bozym R. B. Thompson A. K. Stoddard C. A. Fierke Measuring picomolar intracellular exchangeable zinc in PC-12 cells using a ratiometric fluorescence biosensor ACS Chem. Biol. 2006 1 103 111
85. E. A. Ostrakhovitch P. E. Olsson S. Jiang M. G. Cherian Interaction of metallothionein with tumor suppressor p53 protein FEBS Lett. 2006 580 1235 1238
86. R. Puca L. Nardinocchi H. Gal G. Rechavi N. Amariglio E. Domany D. A. Notterman M. Scarsella C. Leonetti A. Sacchi G. Blandino D. Givol G. D'Orazi Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown Cancer Res. 2008 68 3707 3714
87. R. Puca L. Nardinocchi G. Bossi A. Sacchi G. Rechavi D. Givol G. D'Orazi Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc Exp. Cell Res. 2009 315 67 75
88. P. Yue Z. Li J. Moult Loss of protein structure stability as a major causative factor in monogenic disease J. Mol. Biol. 2005 353 459 473
89. F. M. Boeckler A. C. Joerger G. Jaggi T. J. Rutherford D. B. Veprintsev A. R. Fersht Targeted rescue of a destabilized mutant of p53 by an in silico screened drug Proc. Natl. Acad. Sci. U. S. A. 2008 105 10360 10365
90. V. J. Bykov J. M. Lambert P. Hainaut K. G. Wiman Mutant p53 rescue and modulation of p53 redox state Cell Cycle 2009 8 2509 2517
91. J. M. Lambert P. Gorzov D. B. Veprintsev M. Soderqvist D. Segerback J. Bergman A. R. Fersht P. Hainaut K. G. Wiman V. J. Bykov PRIMA-1 reactivates mutant p53 by covalent binding to the core domain Cancer Cell 2009 15 376 388
92. J. M. Lambert A. Moshfegh P. Hainaut K. G. Wiman V. J. Bykov Mutant p53 reactivation by PRIMA-1(MET) induces multiple signaling pathways converging on apoptosis Oncogene 2009 29 1329 1338
93. A. C. Joerger H. C. Ang A. R. Fersht Structural basis for understanding oncogenic p53 mutations and designing rescue drugs Proc. Natl. Acad. Sci. U. S. A. 2006 103 15056 15061
94. A. C. Joerger H. C. Ang D. B. Veprintsev C. M. Blair A. R. Fersht Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations J. Biol. Chem. 2005 280 16030 16037
95. A. C. Joerger A. R. Fersht Structure-function-rescue: the diverse nature of common p53 cancer mutants Oncogene 2007 26 2226 2242
96. Y. Sun J. Bian Y. Wang C. Jacobs Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compound Oncogene 1997 14 385 393